TNX-102 SL Tablets at 2.8 mg
TNX-CY-F104
Phase 1 small_molecule completed
Quick answer
TNX-102 SL Tablets at 2.8 mg for Healthy Adults is a Phase 1 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Healthy Adults
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed